Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Schizophrenia

  Free Subscription


05.01.2026

1 Acta Psychiatr Scand
2 J Clin Psychopharmacol
1 J Nerv Ment Dis
2 PLoS One
7 Psychiatry Res
2 Psychol Med
6 Schizophr Res


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. WANG CM, Mudiyanselage SPK, Wang PC, Hsu CF, et al
    Digital Social Cognition Training Enhancing Social Cognition in Patients With Schizophrenia: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2025 Dec 28. doi: 10.1111/acps.70060.
    PubMed         Abstract available


    J Clin Psychopharmacol

  2. DE LEON J, de Leon VC, Sanz EJ, De Las Cuevas C, et al
    Clozapine and Suicide in VigiBase: Most Important Fatal Outcome in Young Males and Differences Between Attempted and Completed Suicide.
    J Clin Psychopharmacol. 2026;46:5-15.
    PubMed         Abstract available

  3. FLANAGAN RJ, Rogers JP, Sanchez PLV, Evans L, et al
    Adverse Reactions to Clozapine: Plasma Clozapine in Relation to Smoking Status.
    J Clin Psychopharmacol. 2026;46:36-43.
    PubMed         Abstract available


    J Nerv Ment Dis

  4. NADER G, Ducharme M, Gerretsen P, Fischer C, et al
    Effects of Violence Trajectories on Treatment Outcomes in Schizophrenia Spectrum Disorders.
    J Nerv Ment Dis. 2026;214:13-17.
    PubMed         Abstract available


    PLoS One

  5. HEDEMANN TL, Lu Y, Campitelli S, Hawke LD, et al
    Adaptation and evaluation of a digital dialectical behaviour therapy for youth at clinical high risk for psychosis: A protocol for a feasibility randomized controlled trial.
    PLoS One. 2025;20:e0339163.
    PubMed         Abstract available

  6. CHIU EC, Lee SC
    Development and validation of the leisure lifestyle and satisfaction assessment: A comprehensive tool for evaluating leisure engagement.
    PLoS One. 2025;20:e0338099.
    PubMed         Abstract available


    Psychiatry Res

  7. REDLICH BOSSY M, Muller DR, Cecere G, Vetter S, et al
    Feasibility and efficacy of short cognitive remediation interventions for schizophrenia: a randomized active control trial.
    Psychiatry Res. 2026;356:116881.
    PubMed         Abstract available

  8. SANTANGELO G, Gnazzo M, Baldini V, De Ronchi D, et al
    Unraveling the gender divide: A systematic review of gender-specific differences at the first episode of psychosis.
    Psychiatry Res. 2026;356:116914.
    PubMed         Abstract available

  9. GARCIA-JIMENEZ J, Lafuente-Casanova O, Salas R, Rodriguez C, et al
    12-Month mirror study on the effectiveness and safety of six-month paliperidone palmitate in patients with schizophrenia: A Multicenter Andalusian Cohort (PAPSEM study).
    Psychiatry Res. 2026;356:116903.
    PubMed         Abstract available

  10. SWIECZKOWSKI D, Kwasny A, Cubala WJ
    Cross-sectional analysis of ongoing clinical trials involving lamotrigine for mental disorders: Insights from ClinicalTrials.gov and the EU clinical trials.
    Psychiatry Res. 2026;356:116878.
    PubMed         Abstract available

  11. BROWN WJ, Graziano RC, Babb ZA, Zampogna AM, et al
    Modeling the symptom connections between posttraumatic stress disorder and comorbid severe mental illness.
    Psychiatry Res. 2026;356:116861.
    PubMed         Abstract available

  12. OSTERGAARD SD, Speed M, Hall ASM, Agerbo E, et al
    Genetic liability to mental disorders and being delivered via cesarean section.
    Psychiatry Res. 2026;356:116871.
    PubMed         Abstract available

  13. GRECA E, Belalcazar-Vivas V, Ferrer GF, Michel JJ, et al
    SHAPING MINDS: A systematic review and meta-analysis on the effects of structured exercise in schizophrenia spectrum disorders.
    Psychiatry Res. 2025;357:116919.
    PubMed         Abstract available


    Psychol Med

  14. OOMEN PP, Gangadin SS, de Haan L, de Beer F, et al
    Negative association between cognitive functioning and antipsychotic D(2) receptor occupancy, affinity, and dose after first episode psychosis.
    Psychol Med. 2026;56:e5.
    PubMed         Abstract available

  15. LOZANO-GOUPIL J, Pokorny V, Schiffman J, Silverstein SM, et al
    Reduced interpersonal head synchrony in youth at clinical high risk for psychosis.
    Psychol Med. 2025;55:e387.
    PubMed         Abstract available


    Schizophr Res

  16. IMAM I, Johnson KA, Saluja A, Mesholam-Gately RI, et al
    Improving systems & communities of psychosis care: Proceedings from the 2024 Mass-STEP Conference.
    Schizophr Res. 2025;288:66-68.
    PubMed         Abstract available

  17. TENGFEI C, Shiyu W, Longyu S, Lei C, et al
    S100A8 dysregulation as a neuroimmune nexus: Bridging childhood inflammatory infections to adult schizophrenia-like behaviors via the ELNI model.
    Schizophr Res. 2025;288:47-56.
    PubMed         Abstract available

  18. PENG S, Geng X, Huen WWK, Fang CZ, et al
    Dual glymphatic roles in first-episode schizophrenia and clinical high-risk for psychosis: Evidence from diffusion tensor image analysis along the perivascular space index.
    Schizophr Res. 2025;288:26-34.
    PubMed         Abstract available

  19. ZHANG L, Zhang Z, Strauss GP
    Neighborhood environmental deprivation predicts the generalized neurocognitive deficit in schizophrenia.
    Schizophr Res. 2025;288:18-25.
    PubMed         Abstract available

  20. TORRENS WA, Pablo JN, Berryhill ME, Haigh SM, et al
    Perturbed sensory memory associated with schizotypy symptom load.
    Schizophr Res. 2026;287:129-137.
    PubMed         Abstract available

  21. RODRIGUEZ-CABO B, Catalan A, Aymerich C, Salazar de Pablo G, et al
    Unveiling the prognosis of adult Catatonia: A systematic review.
    Schizophr Res. 2026;287:21-36.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.